These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26138771)

  • 21. Identification of preoperative prediction factors of tumor subtypes for patients with solitary ground-glass opacity pulmonary nodules.
    Li M; Wang Y; Chen Y; Zhang Z
    J Cardiothorac Surg; 2018 Jan; 13(1):9. PubMed ID: 29343293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer.
    Borgia JA; Basu S; Faber LP; Kim AW; Coon JS; Kaiser-Walters KA; Fhied C; Thomas S; Rouhi O; Warren WH; Bonomi P; Liptay MJ
    J Thorac Oncol; 2009 Mar; 4(3):338-47. PubMed ID: 19190517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma cytokine and angiogenic factor profiling identifies markers associated with tumor shrinkage in early-stage non-small cell lung cancer patients treated with pazopanib.
    Nikolinakos PG; Altorki N; Yankelevitz D; Tran HT; Yan S; Rajagopalan D; Bordogna W; Ottesen LH; Heymach JV
    Cancer Res; 2010 Mar; 70(6):2171-9. PubMed ID: 20215520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules.
    Pecot CV; Li M; Zhang XJ; Rajanbabu R; Calitri C; Bungum A; Jett JR; Putnam JB; Callaway-Lane C; Deppen S; Grogan EL; Carbone DP; Worrell JA; Moons KG; Shyr Y; Massion PP
    Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):786-92. PubMed ID: 22374995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Angiopoietin-2 as a Clinical Marker for Lung Cancer in Patients with Solitary Pulmonary Nodules.
    Xu C; Wang W; Wang Y; Zhang X; Yan J; Yu L
    Ann Clin Lab Sci; 2016; 46(1):60-4. PubMed ID: 26927344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients.
    Schotten LM; Darwiche K; Seweryn M; Yildiz V; Kneuertz PJ; Eberhardt WEE; Eisenmann S; Welter S; Sisson BE; Pietrzak M; Wiesweg M; Ploenes T; Hager T; He K; Freitag L; Aigner C; Taube C; Oezkan F
    Eur J Cancer; 2021 Apr; 147():142-150. PubMed ID: 33662689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening.
    Bigbee WL; Gopalakrishnan V; Weissfeld JL; Wilson DO; Dacic S; Lokshin AE; Siegfried JM
    J Thorac Oncol; 2012 Apr; 7(4):698-708. PubMed ID: 22425918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solitary pulmonary nodules: comparison of multi-slice computed tomography perfusion study with vascular endothelial growth factor and microvessel density.
    Bai RJ; Cheng XG; Qu H; Shen BZ; Han MJ; Wu ZH
    Chin Med J (Engl); 2009 Mar; 122(5):541-7. PubMed ID: 19323905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
    Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
    J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexisting pulmonary nodules in operable lung cancer: prevalence and probability of malignancy.
    Ruppert AM; Lerolle U; Carette MF; Lavole A; Khalil A; Bazelly B; Antoine M; Cadranel J; Milleron B
    Lung Cancer; 2011 Nov; 74(2):233-8. PubMed ID: 21511355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased levels of circulating sex hormones as a biomarker of lung cancer in male patients with solitary pulmonary nodules.
    Gu T; Wen Z; Xu S; Hua H; Zhang Z; Wen T; Fu Z; Lv X
    Afr Health Sci; 2014 Jun; 14(2):356-63. PubMed ID: 25320584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited value of shape, margin and CT density in the discrimination between benign and malignant screen detected solid pulmonary nodules of the NELSON trial.
    Xu DM; van Klaveren RJ; de Bock GH; Leusveld A; Zhao Y; Wang Y; Vliegenthart R; de Koning HJ; Scholten ET; Verschakelen J; Prokop M; Oudkerk M
    Eur J Radiol; 2008 Nov; 68(2):347-52. PubMed ID: 17920800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Research on the relationship between serum levels of inflammatory cytokines and non-small cell lung cancer.
    Song XY; Zhou SJ; Xiao N; Li YS; Zhen DZ; Su CY; Liu ZD
    Asian Pac J Cancer Prev; 2013; 14(8):4765-8. PubMed ID: 24083740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging--perfusion differences in malignant and benign lesions.
    Schaefer JF; Vollmar J; Schick F; Vonthein R; Seemann MD; Aebert H; Dierkesmann R; Friedel G; Claussen CD
    Radiology; 2004 Aug; 232(2):544-53. PubMed ID: 15215548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Software volumetric evaluation of doubling times for differentiating benign versus malignant pulmonary nodules.
    Revel MP; Merlin A; Peyrard S; Triki R; Couchon S; Chatellier G; Frija G
    AJR Am J Roentgenol; 2006 Jul; 187(1):135-42. PubMed ID: 16794167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multi-analyte serum test for the detection of non-small cell lung cancer.
    Farlow EC; Vercillo MS; Coon JS; Basu S; Kim AW; Faber LP; Warren WH; Bonomi P; Liptay MJ; Borgia JA
    Br J Cancer; 2010 Oct; 103(8):1221-8. PubMed ID: 20859284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules.
    Markowitz SB; Miller A; Miller J; Manowitz A; Kieding S; Sider L; Morabia A
    Chest; 2007 Apr; 131(4):1028-34. PubMed ID: 17426206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overestimated value of (18)F-FDG PET/CT to diagnose pulmonary nodules: Analysis of 298 patients.
    Li S; Zhao B; Wang X; Yu J; Yan S; Lv C; Yang Y
    Clin Radiol; 2014 Aug; 69(8):e352-7. PubMed ID: 24877581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation.
    Spanu A; Schillaci O; Pirina P; Arru A; Madeddu G; Chessa F; Marongiu P; Solinas ME; Madeddu G
    Oncol Rep; 2006 Oct; 16(4):763-9. PubMed ID: 16969491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer.
    Suwinski R; Giglok M; Galwas-Kliber K; Idasiak A; Jochymek B; Deja R; Maslyk B; Mrochem-Kwarciak J; Butkiewicz D
    BMC Cancer; 2019 May; 19(1):427. PubMed ID: 31068179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.